Koichi Hashizume
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Immunogenicity, reactogenicity, and safety of an mRNA-based seasonal influenza and SARS-CoV-2 multicomponent vaccine, mRNA-1083, in adults aged ≥50 years in Japan.
Journal: Vaccine
Published: April 27, 2026
Pharmacological Correction of Aberrant DSCAML1 Localization by 4-Phenylbutyrate Ameliorates Epileptic Phenotypes in a Mouse Model Harboring the Patient-Specific A2105T Mutation.
Journal: Genes to cells : devoted to molecular & cellular mechanisms
Published: January 07, 2026
Transcriptional features of low-grade neuroepithelial tumors with the BRAF V600E mutation associated with epileptogenicity.
Journal: Genes to cells : devoted to molecular & cellular mechanisms
Published: November 17, 2023
Efficacy and safety of abatacept in biologic-naïve patients with active rheumatoid arthritis by background methotrexate dose: post hoc analysis of a randomized, placebo-controlled, phase 4 study.
Journal: Modern rheumatology
Published: March 05, 2021
Potential involvement of DSCAML1 mutations in neurodevelopmental disorders.
Journal: Genes to cells : devoted to molecular & cellular mechanisms
Published: November 26, 2020
Down syndrome cell adhesion molecule like-1 (DSCAML1) links the GABA system and seizure susceptibility.
Journal: Acta neuropathologica communications
Published: November 13, 2020
Flexible use of copula-type model for dose-finding in drug combination clinical trials.
Journal: Biometrics
Published: October 09, 2020
DSCAM regulates delamination of neurons in the developing midbrain.
Journal: Science advances
Published: November 11, 2019
Abatacept in combination with methotrexate in Japanese biologic-naive patients with active rheumatoid arthritis: a randomised placebo-controlled phase IV study.
Journal: RMD open
Published: August 31, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026